UBS Group’s CERo Therapeutics CERO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.3K | Buy |
2,625
+491
| +23% | +$4.73K | ﹤0.01% | 6983 |
|
2025
Q1 | $31.2K | Buy |
+2,134
| New | +$31.2K | ﹤0.01% | 6624 |
|
2023
Q1 | – | Sell |
-1
| Closed | -$29.7K | – | 9122 |
|
2022
Q4 | $29.7K | Hold |
1
| – | – | ﹤0.01% | 6080 |
|
2022
Q3 | $15K | Buy |
+1
| New | +$15K | ﹤0.01% | 6737 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 7695 |
|